Rademaker; Rik
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rademaker; Rik.The latest application filed is for "multispecific antibodies against cd40 and cd137".
Company Profile
29.20.36
- Rademaker; Rik - Utrecht NL
- RADEMAKER; Rik - Copenhagen V DK
Patent Activity
| Patent | Date |
|---|---|
| Multispecific antibodies against CD40 and CD137 Grant 11,440,966 - Altintas , et al. September 13, 2 | 2022-09-13 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 11,421,024 - Kallunki , et al. August 23, 2 | 2022-08-23 |
| Humanized or chimeric CD3 antibodies Grant 11,359,015 - Rademaker , et al. June 14, 2 | 2022-06-14 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20220064317 - ALTINTAS; Isil ; et al. | 2022-03-03 |
| Antibodies Grant 11,261,254 - Koopman , et al. March 1, 2 | 2022-03-01 |
| Antibodies App 20220048999 - KOOPMAN; Louise ; et al. | 2022-02-17 |
| Antibodies App 20220049013 - SATIJN; David ; et al. | 2022-02-17 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20220033510 - ALTINTAS; Isil ; et al. | 2022-02-03 |
| Antibody Formulation App 20210369842 - ALTINTAS; Isil ; et al. | 2021-12-02 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20210324096 - OVERDIJK; Marije ; et al. | 2021-10-21 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20210317225 - ALTINTAS; Isil ; et al. | 2021-10-14 |
| Antibodies Grant 11,130,819 - Satijn , et al. September 28, 2 | 2021-09-28 |
| Antibodies App 20210292418 - KOOPMAN; Louise ; et al. | 2021-09-23 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210277133 - ALTINTAS; Isil ; et al. | 2021-09-09 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210269541 - ALTINTAS; Isil ; et al. | 2021-09-02 |
| Methods of producing multispecific antibodies against CD40 and CD137 Grant 11,091,557 - Altintas , et al. August 17, 2 | 2021-08-17 |
| Multispecific antibodies against CD40 and CD137 Grant 11,084,882 - Altintas , et al. August 10, 2 | 2021-08-10 |
| Antibodies App 20210230296 - SATIJN; David ; et al. | 2021-07-29 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20210163616 - ALTINTAS; Isil ; et al. | 2021-06-03 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210147522 - KALLUNKI; Pekka ; et al. | 2021-05-20 |
| Antibodies Grant 11,008,399 - Satijn , et al. May 18, 2 | 2021-05-18 |
| Binding agents binding to PD-L1 and CD137 and use thereof Grant 10,968,280 - Altintas , et al. April 6, 2 | 2021-04-06 |
| Antibodies App 20210070877 - SATIJN; David ; et al. | 2021-03-11 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210061892 - KALLUNKI; Pekka ; et al. | 2021-03-04 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20210054057 - KALLUNKI; Pekka ; et al. | 2021-02-25 |
| Anti-DR5 antibodies and methods of use thereof Grant 10,882,913 - Overdijk , et al. January 5, 2 | 2021-01-05 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,800,836 - Kallunki , et al. October 13, 2 | 2020-10-13 |
| Antibodies App 20200277397 - SATIJN; David ; et al. | 2020-09-03 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20200247899 - Kind Code | 2020-08-06 |
| Antibodies Against Pd-l1 App 20200239579 - ALTINTAS; Isil ; et al. | 2020-07-30 |
| Humanized Or Chimeric Cd3 Antibodies App 20200199229 - VAN DEN BRINK; Edward Norbert ; et al. | 2020-06-25 |
| Bispecific Antibodies Against Cd3 And Cd20 App 20200199231 - ENGELBERTS; Patrick ; et al. | 2020-06-25 |
| Binding Agents Binding To Pd-l1 And Cd137 And Use Thereof App 20200165349 - ALTINTAS; Isil ; et al. | 2020-05-28 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,647,764 - Kallunki , et al. | 2020-05-12 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,647,763 - Kallunki , et al. | 2020-05-12 |
| Agents, uses and methods for the treatment of synucleinopathy Grant 10,640,554 - Kallunki , et al. | 2020-05-05 |
| Multispecific Antibodies Against Cd40 And Cd137 App 20200062853 - ALTINTAS; Isil ; et al. | 2020-02-27 |
| Bispecific antibodies against CD3 and CD20 Grant 10,544,220 - Engelberts , et al. Ja | 2020-01-28 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190382473 - KALLUNKI; Pekka ; et al. | 2019-12-19 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190367595 - Kallunki; Pekka ; et al. | 2019-12-05 |
| Agents, Uses And Methods For The Treatment Of Synucleinopathy App 20190367594 - KALLUNKI; Pekka ; et al. | 2019-12-05 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20190315877 - OVERDIJK; Marije ; et al. | 2019-10-17 |
| Humanized Or Chimeric Cd3 Antibodies App 20190284278 - RADEMAKER; Rik ; et al. | 2019-09-19 |
| Humanized or chimeric CD3 antibodies Grant 10,407,501 - Van Den Brink , et al. Sept | 2019-09-10 |
| Antibodies for the treatment of synucleinopathy Grant 10,364,285 - Kallunki , et al. | 2019-07-30 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,482 - Kallunki , et al. | 2019-07-23 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,484 - Kallunki , et al. July 23, 2 | 2019-07-23 |
| Antibodies for the treatment of synucleinopathy Grant 10,358,483 - Kallunki , et al. July 23, 2 | 2019-07-23 |
| Anti-dr5 Antibodies And Methods Of Use Thereof App 20190144554 - OVERDIJK; Marije ; et al. | 2019-05-16 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180179271 - Kallunki; Pekka ; et al. | 2018-06-28 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180179270 - Kallunki; Pekka ; et al. | 2018-06-28 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180127491 - Kallunki; Pekka ; et al. | 2018-05-10 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20180127492 - Kallunki; Pekka ; et al. | 2018-05-10 |
| Bispecific Antibodies Against Cd3 And Cd20 App 20170355767 - ENGELBERTS; Patrick ; et al. | 2017-12-14 |
| Agents, Uses and Methods for the Treatment of Synucleinopathy App 20170015739 - Kallunki; Pekka ; et al. | 2017-01-19 |
| Humanized Or Chimeric Cd3 Antibodies App 20160333095 - VAN DEN BRINK; Edward Norbert ; et al. | 2016-11-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 